myirislogo
23 October, 2018 00:53 IST
My Last 5 Scrips
Company BSE Price (Rs) % Chg
State Bank O 259.95 0.35
Tata Motors 170.55 2.43
Icici Bank 327.00 3.84
Axis Bank 562.00 0.04
I T C 288.25 0.07
Clear All Clear Last
   
NSE Live
Nifty Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Nse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
BSE Live
BSE30 Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Bse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
Watch
Sector Watch
Economy Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Research
Research Reports
Snapshot-Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs and Formulations
BSE:533573NSE:APLLTDBloomberg:ALPM@INReuters:ALEM.BO
Market Lot: 1Face Value: 2ISIN Demat: INE901L01018
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
22-OCT-18 Alembic Pharmaceuticals announced that Aleor Dermaceuticals (Aleor), a 60:40 Joint Venture between Alembic Pharmaceuticals and Orbicular Pharmaceutical Technologies (Orbicular), has successfully cleared its first United States Food and Drugs Administration (USFDA) inspection of its new formulation manufacturing facility located at Karakhadi, Gujarat, India; without any observations. 06-AUG-18 Alembic Pharmaceuticals today announced t...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Alembic Pharma gets tentative nod for Bimatoprost Ophthalmic solution  -IRIS 06-Aug-18
Previous

More


Brief Financials (in Rs. Mn.) 
Period ending (months)31-Mar-2016(12)31-Mar-2015 (12)31-Mar-2014 (12)
Net sales 29798.8020157.0018412.80
Other Income55.105.7031.90
Total Income29853.9020162.7018444.70
Cost of goods sold20014.3016111.9014847.70
OPBDIT9839.604050.803597.00
PAT6981.102866.102382.80
Gross Block---
Equity capital377.00377.00377.00
EPS (Rs.)-15.2012.64
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-15.00 - 32.548.16 - 24.52
Debt / Equity (x)---
Operating margin (% of OI)33.020.119.5
Net margin (% of OI)23.414.212.9
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
Alembic Road
Vadodara
Gujarat-390 003
PHONE
(0265) 2280 550/ 880
FAX
(0265) 2282 506
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer